
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Clinical Trials Xpress (CTX), an initiative of the University of Texas System, has been named by PAREXEL as a member of its Global Site Alliance Network. Within this network, CTX will work side-by-side with PAREXEL to promote more clinical development of drug therapies through research.
Read the full release






